AVGO vs NXE Stock Comparison

AVGO currently leads NXE in this stock comparison, with AIQ scores of 52 vs 35. The clearest difference is quality, while NXE has the stronger momentum profile.

Market data as of Oct 31, 2026 market close· AIQ score gap 17 points
AVGO
Technology
vs
NXE
Energy
AVGO
Broadcom Inc.
Leads
Price
$326
Day move
-5.48%
AIQ Score
52/100
Best edge
Quality
Sector
Technology
NXE
NexGen Energy Ltd.
Price
$8.27
Day move
-4.39%
AIQ Score
35/100
Best edge
Momentum
Sector
Energy

What is the main difference between AVGO and NXE?

AVGO leads the current stock comparison as Broadcom Inc., with the clearest separation coming from quality and the broader AIQ evidence mix.

AlgovestIQ AIQ Comparison

Broadcom Inc. vs NexGen Energy Ltd.

Data as of Oct 31, 2026· market close· Cross-sector · Technology vs Energy· Coverage 62/66 fields· High confidence
AIQ VerdictCompetitiveAIQ Comparison Conviction 8/10

AVGO leads

AVGO leads by 17 AIQ points, primarily on Quality and Risk Resilience, but the lead has narrowed from 33 points over 30 sessions.

Competitive: 3 of 4 evidence groups support AVGO, its lead is narrowing, and its current signal state is conflicted.

Evidence agreement: 3 of 4Comparison trend: Weakening
AVGO

Broadcom Inc.

Leads
AIQ Score
52/100
AIQ Edge Score
5/10
NXE

NexGen Energy Ltd.

AIQ Score
35/100
AIQ Edge Score
2/10

The Algovestiq AIQ Score currently favors AVGO over NXE, 52 versus 35 as of Oct 31, 2026. AVGO's advantage is driven primarily by stronger quality and risk resilience, while NXE holds the stronger momentum profile. AVGO also shows the stronger technical structure relative to its 50-day moving average. 3 of 4 covered evidence groups favor AVGO today, and the comparison is rated Competitive on stability: the leader's advantage has been narrowing. AVGO lead: Weakening — the AIQ differential moved from 33 to 17 points over 30 sessions.

Compare Broadcom Inc. and NexGen Energy Ltd. across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.

Currently unavailable

Performance over time

Total return with distributions reinvested, from daily closes.

AVGO
+627.8%
NXE
+56.6%

Total return comparison

Growth of $10,000, distributions reinvested

AVGO $72,782 · NXE $15,657

Split-adjusted closes; each distribution is reinvested at the close on its ex-dividend date. Taxes and trading costs are not modeled.

Compare AVGO and NXE against another ticker

Open a multi-ticker workspace without changing this focused pair page.

Basic: 2 symbols·Explorer: 3 symbols·Pro and Premium: 5 symbols·Your limit: 2

AIQ Factor Divergence

Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.

AVGO advantage
0
NXE advantage
  • Quality85 vs 25
    AVGO +60
  • Risk Resilience51 vs 37
    AVGO +14
  • Momentum40 vs 46
    NXE +6

3 of 4 evidence groups favor AVGO. AVGO’s edge is concentrated in quality and risk resilience; NXE keeps a meaningful momentum edge.

What changed since the last close

Latest scored session 2026-10-28, compared against the prior scored session 2026-10-27.

AVGO+4 AIQ

Largest factor move: Momentum +16

New signals

  • MACD Bullish Crossover — bullish, momentum, short horizon
NXE+2 AIQ

Largest factor move: Momentum +7

No signal started or stopped since the prior session; its 5 active signals are unchanged.

AVGO's lead widened by 2 AIQ points in the latest session.

Deeper signal detail for each name lives on its own signals page — AVGO and NXE both carry a full feed there.

The central trade-off

AVGO (Broadcom Inc.): the stronger current systematic profile, led by quality and risk resilience.

NXE (NexGen Energy Ltd.): the counter-case, on momentum — but at materially higher volatility, 51% against 43%.

Which one fits your objective

The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.

Balanced

AVGO

AVGO on the overall AIQ Score, which weights Quality and Value most heavily.

Growth

NXE

NXE on combined revenue and EPS growth.

Value

Even

The two are level on Value.

Momentum

NXE

NXE on the Momentum factor, by 6 points.

Lower downside

AVGO

AVGO on Risk Resilience, by 14 points.

Analyst upside

Even

Analyst targets are level or not covered for both names.

AIQ vs Wall Street

Where the systematic read and the analyst consensus line up — and where they do not.

MeasureAVGONXENote
Implied upside to target+55.3%—Level
Target dispersion+49.4%—Lower is tighter analyst agreement
ConsensusBuyStrong BuyContext, not a primary driver
Analysts covering1916Higher coverage generally improves confidence

Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.

AIQ Agreement Matrix

3 of 4 covered evidence groups favor AVGO. A wide gap backed by one group is a weaker case than a narrow gap backed by five.

Evidence groupFavorsReading
AIQ ScoreAVGO52 vs 35
FundamentalsEvenEPS growth 26.5% vs 145.8%; TTM ROE 36.4% vs -16.1%
ValuationNot coveredNot covered
TechnicalsAVGOPrice vs 50-day -7.9% vs -12.9%; vs 200-day -4.3% vs -17.2%
Risk ResilienceAVGORisk Resilience 51 vs 37
Analyst expectationsNot coveredNot covered

✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of AVGO and NXE and are excluded from the count.

AIQ Decision Stability

Competitive

The two are close enough that your objective, not the score, should decide.

  • The AIQ gap is wide at 17 points. (supports the conclusion holding)
  • The leader's advantage has been narrowing. (argues the conclusion is provisional)
  • The leader is throwing conflicting signals. (argues the conclusion is provisional)

Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on AVGO.

How the comparison changed

120 daily snapshots · Jun 29 – Oct 28

AVGO lead: Weakening — the AIQ differential moved from 33 to 17 points over 30 sessions.

Jun 29AVGO leads above the line · NXE leads belowOct 28
Today
AVGO +17
52 vs 35
7 sessions ago
AVGO +17
46 vs 29
30 sessions ago
AVGO +33
65 vs 32
90 sessions ago
NXE +2
43 vs 45

The lead changed hands once in this window, most recently on Aug 21 when NXE moved ahead of AVGO.

AIQ Signal Divergence

Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.

AVGOConflicted

1 bullish / 2 bearish, conflicted

No signal that the other name lacks.

NXEConflicted

1 bullish / 2 bearish / 2 neutral, conflicted

Only NXE

  • Bollinger Band Squeeze — neutral, volatility, short horizon
  • ATR Expansion - Breakout Mode — neutral, volatility, short horizon (4.17%)

Both carry 3 more signals that do not separate them: Death Cross Active, Downtrend Structure Active, MACD Bullish Crossover.

AVGO leads the comparison while carrying a conflicted signal state, which is one reason the stability rating is not higher.

Price vs model alignment

Whether the latest session's price move confirms what the model did over the same session, or contradicts it.

AVGODivergence

Price is down while the AIQ Score moved up 4 points over the same session — price and model disagree (price -5.48%, AIQ +4 points).

NXEDivergence

Price is down while the AIQ Score moved up 2 points over the same session — price and model disagree (price -4.39%, AIQ +2 points).

What would flip this result

A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.

  1. 1NXE closes the Quality gap — currently 60 points behind, the largest single contributor to AVGO's edge.
  2. 2NXE's Death Cross Active resolves — a bearish trend rule currently active against it.
  3. 3AVGO's conflicting signal state resolves bearish — it currently carries 1 bullish and 2 bearish rules at once.
  4. 4The narrowing continues — the lead has already given back 16 points over 30 sessions, and a further 17-point move would eliminate AVGO's advantage entirely.

The full evidence

Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.

Fundamentals

Split
MetricAVGONXE
Revenue growth (YoY)14.9%0%
EPS growth (YoY)26.5%145.8%
Gross margin67%0%
Operating margin43.7%0%
Return on equity (TTM)36.4%-16.1%
Debt to equity0.740.33

Performance

Split across windows
MetricAVGONXE
1 week (5 sessions)4.1%4.8%
1 month (20 sessions)0.2%-2%
3 months (63 sessions)-9.3%-4.1%
6 months (126 sessions)-13.2%-24%
Year to date1.6%-2.8%
1 year (252 sessions)-0.7%2.3%

Technicals

AVGO has the stronger structure
MetricAVGONXE
RSI (14)45.654.7
ADX (14)24.121.5
Price vs 50-day-7.9%-12.9%
Price vs 200-day-4.3%-17.2%
Volatility (1M, annualized)43%51%

Risk

AVGO is the more resilient
MetricAVGONXE
Beta2.182.33
Sharpe ratio0.020.08
Sortino ratio0.030.14
Max drawdown-33.2%-42%
Current drawdown-26.9%-35.8%
Annualized volatility46%54.6%
Value at risk (95%)-4.4%-5.5%

Straight answers

Each answer is regenerated from the current snapshot, not written once and left to age.

Which is better, AVGO or NXE?

On the Algovestiq AIQ Score, AVGO is the stronger of the two as of Oct 31, 2026, scoring 52 against NXE's 35. The edge comes from quality and risk resilience. NXE is not without a case — it holds the better momentum profile, which matters more if that is the objective you are optimizing for. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.

Is AVGO or NXE the better buy right now?

AVGO carries the stronger systematic profile as of Oct 31, 2026, and the comparison is rated Competitive — 3 of 4 covered evidence groups agree. A Competitive rating means the two are close enough that your objective, not the score, should decide.

Why does the AIQ Score favor AVGO over NXE?

The composite weights Quality, Value, Momentum and Risk Resilience. AVGO leads Quality by 60 points; AVGO leads Risk Resilience by 14 points; NXE leads Momentum by 6 points. Where the two split, the factor with the larger weight carries the result.

Which has more analyst upside, AVGO or NXE?

Analyst price targets imply +55.3% upside for AVGO and not covered for NXE. The model and the Street agree here, which is a broader base of evidence than either alone. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.

Which is better value, AVGO or NXE?

Neither name separates on the peer-relative Value factor. The two are level on Value. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.

Which has stronger growth, AVGO or NXE?

NXE on combined revenue and EPS growth. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.

Which has stronger momentum, AVGO or NXE?

NXE on the Momentum factor, by 6 points. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.

Which is riskier, AVGO or NXE?

AVGO is the more resilient of the two, so the other name carries the higher downside risk. AVGO on Risk Resilience, by 14 points. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.

Is AVGO more profitable than NXE?

AVGO leads on the comparable margin measures — gross margin 67% vs 0%; operating margin 43.7% vs 0%; ttm roe 36.4% vs -16.1%.

Is AVGO's lead over NXE getting stronger or weaker?

AVGO lead: Weakening — the AIQ differential moved from 33 to 17 points over 30 sessions. This is measured from 120 daily comparison snapshots between 2026-06-29 and 2026-10-28. The lead has changed hands once in that window, most recently on 2026-08-21, when NXE moved ahead of AVGO.

What would change the AVGO vs NXE verdict?

The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: NXE closes the Quality gap — currently 60 points behind, the largest single contributor to AVGO's edge; NXE's Death Cross Active resolves — a bearish trend rule currently active against it; AVGO's conflicting signal state resolves bearish — it currently carries 1 bullish and 2 bearish rules at once; the narrowing continues — the lead has already given back 16 points over 30 sessions, and a further 17-point move would eliminate AVGO's advantage entirely.

What do the current signals say about AVGO and NXE?

AVGO: 1 bullish / 2 bearish, conflicted. NXE: 1 bullish / 2 bearish / 2 neutral, conflicted. A conflicted state means bullish and bearish rules are active on the same name at once — the technical evidence is not pointing one way, and a decision taken on it carries more timing risk. The most decision-relevant rule on AVGO is Death Cross Active (bearish, long horizon). On NXE it is Death Cross Active (bearish, long horizon).

Compare AVGO and NXE with others

Continue your research

This page answers which of the two. These answer the questions on either side of it.

How this comparison is scored

The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.

The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.

How to use side-by-side comparison →

This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.